Viewing Study NCT05041257


Ignite Creation Date: 2025-12-24 @ 7:01 PM
Ignite Modification Date: 2025-12-27 @ 8:17 PM
Study NCT ID: NCT05041257
Status: COMPLETED
Last Update Posted: 2024-12-20
First Post: 2021-08-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO)
Sponsor:
Organization: